A recent study reveals that individuals who come off popular weight-loss injections like Mounjaro or Wegovy tend to recover lost weight far faster than those who halt traditional lifestyle plans.
Research printed in a leading health publication demonstrates that while obese individuals frequently drop substantial amounts of their body weight while undergoing treatment, the mass returns at an average rate of 0.8 kg per month once they quit.
"Users using these drugs should be aware of the potential of quick rebound weight gain when the therapy concludes," stated lead investigator Dr. Susan Jebb.
Such speed of regain means a return to starting weight within about one and a half years.
Analyzing Approaches
The study, which reviewed 37 of trials involving thousands of patients, compared the outcomes of the injectable medications with older methods.
Researchers emphasize that people who lose weight through dieting typically see a less rapid weight regain—perhaps 100 grams monthly—after stopping.
Understanding the Quick Regain
Doctors propose the way of the injections is key to understanding the amplified rebound.
The injections copy a body's own chemical called GLP-1, which helps regulate appetite.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its endogenous hormone, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Stopping of this hormone supplement leads to appetite is unsuppressed, making excessive eating a significant risk."
A Chronic Condition?
The NHS advise the injections for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
Professionals argue that, given the significant potential of relapse, the therapy is often life-long.
This perspective is reinforced by drug manufacturers, who state that the findings "emphasize the chronic nature of excess weight," similar to managing diseases like high blood pressure.
Patient Testimonies
People who have discontinued the medication describe a powerful return of cravings.
"It felt as if something that goes on and you're instantly starving," recalled a patient.
This challenge is exacerbated if users have not established sustainable lifestyle or habit modifications during treatment.
Significant Use
Recent estimates suggest that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with demand remaining high.
- Adoption is greater among females than males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion obtain the medications through private healthcare rather than public health services.
Ultimately, experts stress that while the jabs are effective agents for shedding pounds, they are not a standalone cure and lasting health benefits hinges on ongoing lifestyle changes.
